Concepedia

Steven Bentivegna

SB

Statistics

Publications

2

Citations

274

H-Index

2

Active since

2008

Affiliations

Pfizer (United States)(Current)

Steven Bentivegna is an author at Pfizer (United States) specializing in molecular oncology, mek inhibition, and dose-limiting toxicity assessment.

Publications per year

2008–2010

2

Publications

2

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral MAPK/ERK Kinase Inhibitor PD-0325901 in Patients with Advanced Cancers

Patricia LoRusso, Smitha Krishnamurthi, John J. Rinehart et al. · Clinical Cancer Research · 2010 · 250 citations

, , +17

Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD)

Steven Bentivegna, Jianbiao Zheng, Eugeni Namsaraev et al. · Human Mutation · 2008 · 24 citations

, , +17

1–2 of 2